L3VLUP
ProSign in

ORIC in the 13F filings

Oric Pharmaceuticals Inc · CUSIP 68622P109

Sector · Pharmaceuticals and biotechnologyTheme · Healthcare: biopharma and medtech· L3VLUP-definedTheme · Pharmaceutical preparations
Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q2 2021Q1 2021
Quarter end
30 Jun 2021
the date the book describes
Filed
16 Aug 2021
up to 45 days after the quarter end
Managers listing it
1
at least, of 95 tracked, among listed positions
Comparable managers
93
filed both Q1 2021 and Q2 2021; 1 listed it in both
Shares listed
944,001
combined, among listed positions
Reported value
$17m
combined, at the quarter end

Managers listing ORIC in Q2 2021

Share of 13F value is the position’s reported value over everything the manager reported that quarter. The share change is against Q1 2021, and only where both filings list the position. A rise in value with no rise in shares is the price, not buying.

1 of 1 holder

ActionFiling
Point72 Asset Management LP944,001$17m0.08%Trimmed-341,64616 Aug 2021 (the filing on sec.gov)

Largest increases and reductions, by shares

Q1 2021 to Q2 2021, among managers that listed it in both quarters or opened it.

Increases

No increase among listed positions.

Reductions

New positions and exits

At least these many: a manager is shown exiting only where its own filing shows the position gone.

New (0)

No new position among listed positions.

Exited (0)

No exit shown by a manager’s own filing.

Ownership over time

Every quarter on file. A quarter-end value moves with the price as well as with the shares held; buyers and sellers count comparable managers, by shares.
1 in Q3 2024 to 2 in Q2 2026

Tracked managers listing it, at least.

0123Q1 2021Q1 2024Q3 2024Q1 2025Q3 2025Q1 2026Q2 2026
the quarter shown share split complete books; unmarked quarters rest on listed positionsClick a quarter to open it.
ORIC by quarter
QuarterHoldersReported valueBuyersSellers
Q1 20211$31mn.a.n.a.
Q2 20211$17mn.a.n.a.
Q1 20241$55m10
Q2 20241$28m00
Q3 20241$41m00
Q4 20242$42m20
Q1 20251$37m10
Q2 20252$96m10
Q3 20252$110m01
Q4 20251$54m145
Q1 20263$90m915
Q2 20262$69m148

Compare with…

Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.

ORIC and LLY →ORIC and JNJ →ORIC and VRTX →Choose a stock to compare with ORIC →

How much of the picture this is

A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.

Which funds own ORIC, latest filings →Back to the 13F Explorer →